6:03 AM ET
8-K
M&A Deal
XWELL Signs $2.7M M&A Deal with Express Wellness Group, LLC
XWELL's subsidiary XpresTest repurchased all outstanding restricted stock awards for $2.7 million to simplify its capitalization ahead of a previously announced divestiture. This action ensures XWELL now owns 100% of XpresTest before the final sale of the entity to Express Wellness Group, LLC. The repurchase price of $9,634.09 per share matches the valuation agreed upon in the original securities purchase agreement.
- Value
- $2.7M
- Counterparty
- Express Wellness Group, LLC